Empowering New Zealand Nurses for Excellence in Healthcare
Bicultural Structure
Membership includes belonging to a bicultural organisation focused on professional nursing issues and community health.
Insurance Coverage
Members receive up to $1 million indemnity insurance in New Zealand (not applicable for retired members). (Conditions apply).
Access to Publications
Members have access to the ‘Nursing Praxis in Aotearoa New Zealand’ journal.
Influence and Networking
Members contribute to a significant influencer in health policy decision-making and join a dynamic network of professional nurses committed to high standards of practice.
12 February 2026
Nurse Practitioner - Multiple permanent, part-time positions
We have multiple permanent, part-time positions available We operate 24/7 and the role will be rostered to cover any shifts within the operating hours. Ko tāuake mahi | What you will be doing This is an exciting opportunity for nurse practitioners to be part of the Pegasus Health 24 Hour Surgery team. The nurse practitioner role is part of the Advanced Nursing Practice Team and works to improve sustainable access to and standards of clinical care for people accessing acute level services....
12 February 2026
Invitation to provide feedback on changes to how the Pharmaceutical Schedule will work
Pharmac is redeveloping the Pharmaceutical Schedule to be better aligned with modern funding arrangements and digital standards. The Schedule was first published in 1994 and has grown significantly over the last three decades. As its scope has expanded, so has the complexity of the products and funding arrangements it needs to reflect. The digital systems that support the Schedule are also outdated and need replacing to ensure information can be updated quickly and consistently. We are...
11 February 2026
Discontinuation: Humalog, Humulin NPH, Humulin 30/70, Humulin R 10 ml insulin vials.
We are writing to inform you that t he supplier Eli Lilly are discontinuing 4 insulins in the 10ml vial presentation. The 3ml penfill presentations remain available. Insulin Type Brand Presentation Date Supplier stops selling Insulin lispro Humalog Inj 100 u per ml, 10 ml vial End June 2026 Insulin isophane Humulin NPH Inj human 100 u per ml, 10 ml vial End June 2026 Insulin isophane with insulin neutral Humulin 30/70 Inj human with neutral insulin 100 u per ml, 10 m l vial End June...
11 February 2026
Pharmac confirms changes to simplify biologic medicine funding criteria
We’re letting you know that Pharmac has made a decision to change the funded access criteria for infliximab, etanercept, secukinumab and rituximab.These changes update the Special Authority and Hospital Indication Restrictions for these medicines to simplify and align the criteria where possible. Most of the changes relate to wording and consistency, and the overall intent of the criteria remains the same. However, in some instances we have made more substantive changes, including: extending...
9 February 2026
Pharmac decision: Improving access to treatments in the community for trauma and medical emergencies, and ketamine for palliative care
Please follow this link to the Pharmac decision regarding improving access to treatments in the community for trauma and medical emergencies, and ketamine for palliative care . We want to make sure that everyone who needs to know about this decision is aware of it. Please share this information with people you think might be interested. Ngā mihi Pharmac | Te Pātaka Whaioranga | P: +0800 660 050| www.pharmac.govt.nz
9 February 2026
Nurse Practitioner – Join Our Supportive Team in Te Awamutu
Nurse Practitioner – Join Our Supportive Team in Te Awamutu Mahoe Medical is looking for a motivated and positive Nurse Practitioner to join our friendly, well-established team in Te Awamutu, Waikato . We are a Cornerstone-accredited practice with a strong culture of teamwork, learning, and support. Our clinic has extensive experience in training and currently supervises GPEP registrars , reflecting our commitment to clinical excellence and mentoring. What we offer $90.00 per hour A highly...
9 February 2026
Pharmac decision: Improving access to treatments in the community for trauma and medical emergencies, and ketamine for palliative care
Please follow this link to the Pharmac decision regarding improving access to treatments in the community for trauma and medical emergencies, and ketamine for palliative care . We want to make sure that everyone who needs to know about this decision is aware of it. Please share this information with people you think might be interested. Ngā mihi Pharmac | Te Pātaka Whaioranga | P: +0800 660 050| www.pharmac.govt.nz
9 February 2026
Pharmac Update: Primary Care Prescribers | 06 February 2026
Below is the latest information on Pharmac consultations, notifications, and supply issues for Primary Care Prescribers for week 06 February 2026. It includes information on: New updates Resolved Supply Issues 12-month prescriptions – Pharmac’s key messages for prescribers From 1 February 2026, medicines and other products are funded for up to 12 months on a single prescription. Details of all Schedule changes are included in our decision notification, linked here: Decision on changes to...
5 February 2026
RN - to support the development of New Zealand nursing procedures
Looking for a new challenge? We are seeking a passionate Registered Nurse to support the development of New Zealand nursing procedures. Lippincott is offering a part-time, work-from-home, flexible, freelance clinical editor role. Please see job description attached.
5 February 2026
New medicine supply notices
Iloprost (Vebulis) nebulisers (Pharmacode: 2643006) Supplies of Vebulis iloprost nebulisers are low throughout New Zealand. An unapproved alternative was listed from 9 February. Details and a patient flyer are available. Updated medicine supply notices Methylphenidate: Supply issue Concerta: 27 mg out of stock, limited supply of 18 and 36 mg, 54 mg available Ritalin: All strengths available Rubifen: All strengths available Sandoz XR: All strengths available Teva: All strengths available,...
4 February 2026
Proposal to widen access to brentuximab vedotin for systemic anaplastic large cell lymphoma \
We are seeking feedback on a proposal to widen access to brentuximab vedotin for systemic anaplastic large cell lymphoma, to improve the lives of around twelve people in New Zealand in the first year of funding. Please follow this link to the consultation. We welcome your feedback on this proposal at consult@pharmac.govt.nz . Consultation is open until 5pm Thursday 19 February 2026. If there are people, you think would be interested in providing feedback to this consultation, please share...
4 February 2026
Proposal to widen access to brentuximab vedotin for systemic anaplastic large cell lymphoma
We are seeking feedback on a proposal to widen access to brentuximab vedotin for systemic anaplastic large cell lymphoma, to improve the lives of around twelve people in New Zealand in the first year of funding. Please follow this link to the consultation. We welcome your feedback on this proposal at consult@pharmac.govt.nz . Consultation is open until 5pm Thursday 19 February 2026. If there are people, you think would be interested in providing feedback to this consultation, please...
3 February 2026
Cardiometabolic issues with antidepressants
A systematic review in The Lancet 1 outlined the cardiometabolic issues with antidepressants.There were a few surprises: None had significant QT interval issues. Systolic BP went up with amitriptyline and fluoxetine and down with nortriptyline. Weight loss was observed with bupropion, sertraline, citalopram, paroxetine, and venlafaxine. Weight gain was found with amitriptyline 1.6 kg and mirtazapine 0.87 kg. Heart rate increased (beats per minute) to 13.77 for nortriptyline, 9.25 for...
2 February 2026
Medicinal Cannabis Agency
The Misuse of Drugs (Medicinal Cannabis) Regulations 2019 (the Regulations) set the minimum quality standard that medicinal cannabis products and ingredients must meet before they can be supplied in New Zealand. Importers, manufacturers, and suppliers must apply for assessment and provide evidence to the Medicinal Cannabis Agency to verify that their products meet the minimum quality standard. Aurora Half Moon has been verified as meeting the minimum quality standard. More information on the...
2 February 2026
Pharmac Update: Primary Care Prescribers | 30 January 2026
Below is the latest information on Pharmac consultations, notifications, and supply issues for Primary Care Prescribers for week 30 January 2026. It includes information on: New updates R esolved Supply Issues 12-month prescriptions – Pharmac’s key messages for prescribers From early 2026 medicines and other products will be funded for up to 12 months on a single prescription. This decision means that funding of medicines and other products will be aligned with the amended regulations. This...
2 February 2026
From Perimenopause to ACNES: Meet the Allevia Hospitals Experts at Symposium 2026
Allevia Hospitals is one of New Zealand’s largest private surgical hospital providers, with leading medical specialists. Here's their team for the Symposium, ready to provide you with thorough and timely updates across a wide range of topics – from understanding perimenopausal bleeding patterns, weight-loss medication, managing nasal symptoms, to diagnosing and treating Anterior Cutaneous Nerve Entrapment Syndrome (ACNES): Wal Baraza | Jacob Munro | Craig Ball | Nadya York | Vincent...
1 February 2026
Pharmac confirms decision to continue funding national and regional level storage and distribution services for funded vaccines
Pharmac has confirmed the decision to continue funding national and regional level storage and distribution services for funded vaccines through agreements with the following suppliers: DHL Supply Chain (New Zealand) Limited (“DHL”) – for the supply of various national vaccines storage and distribution services Pharmacy Retailing (NZ) Limited trading as ProPharma (“ProPharma”) – for the supply of various regional vaccines storage and distribution services From 1 February 2026, the provider of...
1 February 2026
NP roles - opportunities across New Zealand
Kickstart the New Year with a Nurse Practitioner role in the location you love! Step into the year ahead with a fresh role that brings renewed purpose to your nursing career. Start the next chapter of your medical journey with Third Age Health, New Zealand’s leading and most trusted provider of general practice healthcare in Aged Residential Care. Together, we can deliver meaningful, person-centred care to older adults across the country. We’re expanding our team nationwide and are looking...
1 February 2026
Pharmac funds a new strength of thiamine hydrochloride injection
Pharmac will fund a new strength of thiamine hydrochloride injection, 50 mg per ml (2 ml ampoule), for use in Health New Zealand | Te Whatu Ora hospitals, from 1 April 2026. Pharmac currently lists thiamine hydrochloride injection 100 mg per ml (1 ml vial and 2 ml vials) and injection 125 mg per ml (2 ml vial) in Part II of Section H of the Pharmaceutical Schedule. None of these line items have a contracted product and we understand most products meeting these descriptions are supplied under...
28 January 2026
Continuing Professional Development
Less than 8 weeks to go! Goodfellow Symposium 2026 In the meantime, here are our latest webinars and podcasts: Adult ADHD: From diagnosis to long-term management WEBINAR 3 February, 7.30pm: Join Psychiatrist David Codyre who will provide practical guidance on continuing ADHD care once treatment has begun. Register here Ovarian cancer: diagnosis to treatment WEBINAR 10 February, 7.30pm: Join Gynae-Oncologist Cecile Bergzoll on offering practical guidance to ovarian cancer patients. ...
Areas of interest
